AGILENT TECHNOLOGIES, INC. Agilent Technologies, Inc. Share Price
Equities
A
US00846U1016
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 130.4 USD | -0.77% |
|
-13.44% | -6.20% |
| 05-30 | A new phase for the market |  |
| 05-30 | UBS Cuts Price Target on Agilent Technologies to $141 From $155, Keeps Neutral Rating | MT |
| Sales 2024 * | 6.46B 507B | Sales 2025 * | 6.88B 540B | Capitalization | 38.03B 2,985B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.35B 106B | Net income 2025 * | 1.44B 113B | EV / Sales 2024 * | 6.05 x |
| Net Debt 2024 * | 1.06B 83.58B | Net Debt 2025 * | 1.46B 114B | EV / Sales 2025 * | 5.74 x |
| P/E ratio 2024 * |
28.1
x | P/E ratio 2025 * |
26.2
x | Employees | 18,000 |
| Yield 2024 * |
0.72% | Yield 2025 * |
0.76% | Free-Float | 99.67% |
More Fundamentals
* Assessed data
More news
Latest transcript on Agilent Technologies, Inc.
More recommendations
More press releases
More news
| 1 day | -0.77% | ||
| 1 week | -13.44% | ||
| 1 month | -4.84% | ||
| 3 months | -5.06% | ||
| 6 months | +2.04% | ||
| Current year | -6.20% |
1 week
125.30
151.19
1 month
125.30155.35
Current year
125.30155.35
1 year
96.80155.35
3 years
96.80179.57
5 years
61.13179.57
10 years
33.12179.57
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | - | |
Robert McMahon
DFI | Director of Finance/CFO | 55 | 02/08/18 |
John Kohl
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Heidi Fields
BRD | Director/Board Member | 69 | 31/01/00 |
Boon Hwee Koh
CHM | Chairman | 73 | 20/05/03 |
Dow Wilson
BRD | Director/Board Member | 64 | 19/03/18 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.29% | 2 M€ | -.--% | ||
| 2.57% | 2 M€ | -25.75% | ||
| 2.28% | 9 M€ | -.--% | ||
| 1.95% | 105 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/05/24 | 130.4 | -0.77% | 5,333,147 |
| 30/05/24 | 131.4 | -9.66% | 5,138,548 |
| 29/05/24 | 145.5 | -1.84% | 1,603,212 |
| 28/05/24 | 148.2 | -1.63% | 1,366,918 |
| 24/05/24 | 150.7 | +0.07% | 784,333 |
Delayed Quote Nyse, May 31, 2024 at 09:00 pm
More quotes
Agilent Technologies, Inc. specializes in the design, manufacturing and marketing of measurement instruments intended primarily for the communications, electronics, life sciences, and chemistry sectors. The activity is organized mainly around three families of products:
- electronic measurement instruments;
- bio-analytical measurement instruments: used to identify, quantify, and analyze the physical and biological properties of substances and products;
- measurement instruments for semiconductors.
Net sales break down by source of income between sales of products (73.9%) and services (26.1%).
Net sales are distributed geographically as follows: the United States (40%), China (34.3%) and other (25.7%).
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
130.4
USD
Average target price
141.1
USD
Spread / Average Target
+8.21%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -6.20% | 38.03B | |
| +7.01% | 217B | |
| +11.01% | 190B | |
| +19.20% | 143B | |
| +30.79% | 111B | |
| +1.48% | 64.59B | |
| +13.95% | 52.36B | |
| -0.16% | 48.45B | |
| +0.91% | 35.61B | |
| +19.95% | 30.31B |
- Stock Market
- Equities
- A Stock
